ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

DeVita Asks Panel For Help On Filling Vacancies, Object To “Effort To Get Us Back To 1970 Level”

November 21, 1980

Blacks Half As Likely To Get Surgery For Esophageal Cancer

January 28, 2005

In Brief: City of Hope Wins $5.5M Grant From NIA; Comis To Head Group Chairmen’s Committee

November 23, 1997

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

NCI-Approved Clinical Trials

July 25, 2003

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984